Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma

Gynecologic Oncology

Volumn 64, Issue 3, 1997, Pages 468-472

  Al Saleh, E ^a   Hoskins, P J ^a   Pike, J A ^a   Swenerton, K D ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; DEXAMETHASONE; ETOPOSIDE; ONDANSETRON;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; STOMATITIS; SURVIVAL TIME; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 0031105333     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4567     Document Type: Article

References (17)

1. 1. Bonomi P, Blessing JA, Stehman FB, DiSaia PJ, Walton L, Major FJ: Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. J Clin Oncol 3:1079-1085, 1985
2. 2. Arseneau J, Blessing JA, Stehman FB, McGhee R: A phase II study of carboplatin in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study). Invest New Drugs 4:187-191, 1986
3. 3. Lira-Puerto V, Silva A, Morris M, Martinez R, Groshen S, Morales-Canfield F, Tenorio F, Muggia F: Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother Pharmacol 28:391-396, 1991
4. 4. Alberts DS, Kronmal R, Baker LH, Stock-Novack DL, Surwit EA, Boutselis JG, Hannigan EV: Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: A Southwest Oncology Group Study. J Clin Oncol 5:1791-1795, 1987
5. 5. Picozzi VJ, Sikic BI, Carlson RW, Koretz M, Ballon SC: Bleomycin, mitomycin and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: A phase II study of the Northern California Oncology Group. Cancer Treat Rep 69:903-905, 1985
6. 6. Giannone L, Brenner DE, Jones HW, Greco FA, Burnelt LS: Combination chemotherapy for patients with advanced carcinoma of the cervix: Trial of mitomycin C, vincristine, bleomycin and cisplatin. Gynecol Oncol 26:178-182, 1987
7. 7. Sugimori H, Iwasaka T, Fukuda K, Hayashi Y, Hachisuga T: Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C and cisplatin. Gynecol Oncol 34:180-182, 1989
8. 8. Rustin GS, Newlands ES, Southcott BM, Singer A: Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix. Br J Obstet Gynecol 94:1205-1211, 1987
9. 9. Slayton RE, Creasman WT, Petty W, Burdy B, Blessing JA: Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: A Gynecologic Oncology Group Study. Cancer Treat Rep 63:2089-2092, 1979
10. 10. Slevin ML, Clark PI, Joel SP, Thompson P, Talbot D, Price C, Wrigley PFM: A randomized trial to examine the effect of more extended scheduling of etoposide administration in small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 8:236, 1989 (abstract 921)
11. 11. Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G, Thiriaux J, Cordier R, Einet C, Berchier MC, Sergysels R, Mommen P, Paesmans M: A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 8:1556-1562, 1990
12. 12. Kredenster DC: Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix. Gynecol Oncol 43:145-148, 1991
13. 13. Durand RE, Goldie JH: Interaction of etoposide and cisplatin in an in vitro tumor model. Cancer Treat Rep 71:673-679, 1987
14. 14. Potter EM, Hatch KD, Potter MY, Shingleton HM, Baker VV: Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 63:1283-1286, 1989
15. 15. Lavoie A, Ouellet P, Tessier C: Chemotherapy of advanced cervical cancer. Proc Annu Meet Am Soc Clin Oncol 12:A 889, 1983 (abstract)
16. 16. Leminen A, Alttan H, Stenman UH, Lehtovira P: Chemotherapy as initial treatment for cervical carcinoma: Clinical and tumor marker response. Acta Obstet Gynecol Scand 71:293-297, 1992
17. 17. Maksymiuk AW, Jett JR, Earle JD, Su JQ, Diegert FA, Mailliard JA, Kardinal G, Krook JE, Veeder MH, Wiesenfeld M, Tschetter LK, Levitt R: Sequencing and schedule effects of cisplatin plus etoposide in small cell lung cancer: Results of a north central cancer treatment group randomized clinical trial. J Clin Oncol 12:70-76, 1994